This report provides a comprehensive analysis of AstraZeneca's strategic management approach, encompassing its business strategies, resources, and capabilities, with a particular focus on its response to the COVID-19 pandemic. The report delves into AstraZeneca's key strategies over the past five years, highlighting adaptations made in light of the pandemic and outlining future strategic directions. It examines the company's resources and capabilities, including physical, human, financial, intellectual, and social capital, and assesses their alignment with the established business strategies. Furthermore, the report investigates AstraZeneca's implementation of environmental sustainability practices, emphasizing the company's commitment to addressing climate change and promoting environmental responsibility. The analysis includes an examination of the company's efforts to minimize environmental impacts throughout the product lifecycle and integrate sustainability into its operations. This report aims to provide a detailed understanding of AstraZeneca's strategic decisions and sustainability initiatives within the competitive pharmaceutical industry.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
